182 related articles for article (PubMed ID: 38753434)
21. The blood proteomic signature of early-onset pediatric atopic dermatitis shows systemic inflammation and is distinct from adult long-standing disease.
Brunner PM; He H; Pavel AB; Czarnowicki T; Lefferdink R; Erickson T; Canter T; Puar N; Rangel SM; Malik K; Estrada Y; Krueger JG; Guttman-Yassky E; Paller AS
J Am Acad Dermatol; 2019 Aug; 81(2):510-519. PubMed ID: 31009665
[TBL] [Abstract][Full Text] [Related]
22. Atopic Dermatitis: Striving for Reliable Biomarkers.
Mastraftsi S; Vrioni G; Bakakis M; Nicolaidou E; Rigopoulos D; Stratigos AJ; Gregoriou S
J Clin Med; 2022 Aug; 11(16):. PubMed ID: 36012878
[TBL] [Abstract][Full Text] [Related]
23. Current and emerging biologic and small molecule therapies for atopic dermatitis.
Li R; Hadi S; Guttman-Yassky E
Expert Opin Biol Ther; 2019 Apr; 19(4):367-380. PubMed ID: 30672355
[TBL] [Abstract][Full Text] [Related]
24. Novel investigational therapies for atopic dermatitis.
Ibler KS; Jemec GB
Expert Opin Investig Drugs; 2015 Jan; 24(1):61-68. PubMed ID: 25201033
[TBL] [Abstract][Full Text] [Related]
25. Target-oriented therapy: Emerging drugs for atopic dermatitis.
Lauffer F; Ring J
Expert Opin Emerg Drugs; 2016; 21(1):81-9. PubMed ID: 26808004
[TBL] [Abstract][Full Text] [Related]
26. Human and computational models of atopic dermatitis: A review and perspectives by an expert panel of the International Eczema Council.
Eyerich K; Brown SJ; Perez White BE; Tanaka RJ; Bissonette R; Dhar S; Bieber T; Hijnen DJ; Guttman-Yassky E; Irvine A; Thyssen JP; Vestergaard C; Werfel T; Wollenberg A; Paller AS; Reynolds NJ
J Allergy Clin Immunol; 2019 Jan; 143(1):36-45. PubMed ID: 30414395
[TBL] [Abstract][Full Text] [Related]
27. Updates in atopic dermatitis for the primary care physician: A review of advances in the understanding and treatment of atopic dermatitis.
Choo ZY; Mehlis SL; Joyce JC
Dis Mon; 2024 Apr; 70(4):101687. PubMed ID: 38278753
[TBL] [Abstract][Full Text] [Related]
28. Integrating multi-omics approaches in deciphering atopic dermatitis pathogenesis and future therapeutic directions.
Nakajima S; Nakamizo S; Nomura T; Ishida Y; Sawada Y; Kabashima K
Allergy; 2024 Jun; ():. PubMed ID: 38837434
[TBL] [Abstract][Full Text] [Related]
29. Impact of a Decade of Research Into Atopic Dermatitis.
Arkwright PD; Koplin JJ
J Allergy Clin Immunol Pract; 2023 Jan; 11(1):63-71. PubMed ID: 36162801
[TBL] [Abstract][Full Text] [Related]
30. Biomarkers for phenotype-endotype relationship in atopic dermatitis: a critical review.
Park CO; Kim SM; Lee KH; Bieber T
EBioMedicine; 2024 May; 103():105121. PubMed ID: 38614010
[TBL] [Abstract][Full Text] [Related]
31. Identification of unique proteomic signatures in allergic and non-allergic skin disease.
Wang J; Suárez-Fariñas M; Estrada Y; Parker ML; Greenlees L; Stephens G; Krueger J; Guttman-Yassky E; Howell MD
Clin Exp Allergy; 2017 Nov; 47(11):1456-1467. PubMed ID: 28703865
[TBL] [Abstract][Full Text] [Related]
32. The atopic dermatitis blood signature is characterized by increases in inflammatory and cardiovascular risk proteins.
Brunner PM; Suárez-Fariñas M; He H; Malik K; Wen HC; Gonzalez J; Chan TC; Estrada Y; Zheng X; Khattri S; Dattola A; Krueger JG; Guttman-Yassky E
Sci Rep; 2017 Aug; 7(1):8707. PubMed ID: 28821884
[TBL] [Abstract][Full Text] [Related]
33. Beneficial Effects of Antioxidant Furfuryl Palmitate in Non-pharmacologic Treatments (Prescription Emollient Devices, PEDs) for Atopic Dermatitis and Related Skin Disorders.
Pigatto PD; Diani M
Dermatol Ther (Heidelb); 2018 Sep; 8(3):339-347. PubMed ID: 29790104
[TBL] [Abstract][Full Text] [Related]
34. High-throughput proteomic analysis of chronic inflammatory skin diseases: Psoriasis and atopic dermatitis.
Traks T; Reemann P; Eskla KL; Ottas A; Jagomäe T; Liira R; Ilves L; Jaks V; Raam L; Abram K; Kingo K
Exp Dermatol; 2024 Apr; 33(4):e15079. PubMed ID: 38654506
[TBL] [Abstract][Full Text] [Related]
35. Multi-Omics Research Strategies for Psoriasis and Atopic Dermatitis.
Guo Y; Luo L; Zhu J; Li C
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175722
[TBL] [Abstract][Full Text] [Related]
36. Recent developments and advances in atopic dermatitis and food allergy.
Sugita K; Akdis CA
Allergol Int; 2020 Apr; 69(2):204-214. PubMed ID: 31648922
[TBL] [Abstract][Full Text] [Related]
37. Microbiome modulators for atopic eczema: a systematic review of experimental and investigational therapeutics.
Greenzaid JD; Chan LJ; Chandani BM; Kiritsis NR; Feldman SR
Expert Opin Investig Drugs; 2024 Apr; 33(4):415-430. PubMed ID: 38441984
[TBL] [Abstract][Full Text] [Related]
38. Burden of Atopic Dermatitis in Adults and Adolescents: a Systematic Literature Review.
Fasseeh AN; Elezbawy B; Korra N; Tannira M; Dalle H; Aderian S; Abaza S; Kaló Z
Dermatol Ther (Heidelb); 2022 Dec; 12(12):2653-2668. PubMed ID: 36197589
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic Potential of Lebrikizumab in the Treatment of Atopic Dermatitis.
Loh TY; Hsiao JL; Shi VY
J Asthma Allergy; 2020; 13():109-114. PubMed ID: 32104006
[TBL] [Abstract][Full Text] [Related]
40. Leveraging Multilayered "Omics" Data for Atopic Dermatitis: A Road Map to Precision Medicine.
Ghosh D; Bernstein JA; Khurana Hershey GK; Rothenberg ME; Mersha TB
Front Immunol; 2018; 9():2727. PubMed ID: 30631320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
